Merimepodib (Vertex)

IDrugs. 2003 Apr;6(4):372-6.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antiviral Agents / adverse effects
  • Antiviral Agents / metabolism
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use*
  • Antiviral Agents / toxicity
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Hepatitis C / drug therapy*
  • Humans
  • Structure-Activity Relationship

Substances

  • Antiviral Agents